Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

SELL
$15.79 - $22.6 $1,547 - $2,214
-98 Reduced 0.37%
26,702 $457,000
Q4 2022

Feb 14, 2023

SELL
$15.5 - $22.76 $3,100 - $4,552
-200 Reduced 0.74%
26,800 $524,000
Q3 2022

Nov 10, 2022

BUY
$12.37 - $18.41 $333,990 - $497,070
27,000 New
27,000 $431,000
Q2 2020

Aug 12, 2020

SELL
$13.32 - $22.61 $2,557 - $4,341
-192 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$11.07 - $24.23 $2,125 - $4,652
192 New
192 $4,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $890M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.